When it comes to treating unresectable hepatocellular carcinoma (uHCC), a type of liver cancer, lenvatinib is often the go-to treatment. But how does it stack up against other options? Researchers used a clever method called inverse probability of treatment weighting (IPTW) and network meta-analysis
The future of bitcoin is looking bright. With the new presidential administration in 2024, we might see a surge in crypto-friendly policies. Some states are already considering bills to make their laws more open to cryptocurrencies like bitcoin. Many people believe that bitcoin is a great way to pro
Robert F. Kennedy Jr. is setting his sights on Capitol Hill, hoping to become the next U. S. health secretary. His visit won't be all smiles, though. Senators have their eyes on his past comments about vaccines and the food industry. They're expected to grill him on his vaccine stance, specifically
In China, hepatitis B (Hep B) is a significant health concern, but surprisingly, not many people are getting treated. A big reason for this is that many folks don't fully understand what Hep B is, how it's treated, or how to find proper medical care. This understanding is what we call health literac
Eating disorders can cause a lot of trouble for families and friends. They can lead to stress, relationship problems, and financial strain. But, not much is known about how these disorders affect the people who care for those struggling with them, especially when the treatment is done in a residenti
Ever heard of hyperphosphatemia? It's a problem that many people with advanced chronic kidney disease (CKD) face. High phosphorus levels can lead to issues like hormone imbalances, bone problems, and even heart risks. The good news is that there are new treatments available. But the real question is
Investors always want to boost their portfolios. One smart way to do this is by looking at forecasts for the coming year. This year, we're not focusing on the usual big names like Meta, Amazon, or Tesla. Instead, let's shine a light on seven smaller, but promising stocks. TG Therapeutics (TGTX) is
Robert F. Kennedy Jr. , known for his liberal views, is facing a tough road on Capitol Hill. His nomination as health and human services secretary has Democrats divided. While some agree with his views on corporate influence and food additives, others worry his anti-vaccine stance and controversial
Ever wondered how long a man with prostate cancer should live to choose less aggressive treatment? That’s what researchers are trying to figure out. They’re looking into how patients feel about the balance between risk of cancer death and nasty side effects from treatment. The goal? To find out at w
Imagine this: A coin called Fartcoin has seen its value shoot up over a week to over $700 million! You might wonder, why is this happening? It’s all tied to a wave of investment in cryptocurrencies, like bitcoin, which has been pushed by Donald Trump’s victory. The crypto market is full of speculato
